NDC 42799-709 – Yargesa

Miglustat 100 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC42799-709

Product details

Brand name
Yargesa
Generic name
Miglustat
Labeler
Edenbridge Pharmaceuticals LLC.
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA209821
Marketed since
August 6, 2020
Listing expires
December 31, 2026
Pharmacologic class
Enzyme Stabilizer; Glucosylceramide Synthase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Yargesa →

Package NDC codes (1)

Package NDCDescriptionSince
42799-709-151 BLISTER PACK in 1 CARTON (42799-709-15) / 15 CAPSULE in 1 BLISTER PACKOct 31, 2023